InvestorsObserver
×
News Home

Can Sio Gene Therapies Inc (SIOX) Stock Rise to the Top of Healthcare Sector Friday?

Friday, December 16, 2022 01:35 PM | InvestorsObserver Analysts

Mentioned in this article

Can Sio Gene Therapies Inc (SIOX) Stock Rise to the Top of Healthcare Sector Friday?

Sio Gene Therapies Inc (SIOX) is around the bottom of the Healthcare sector according to InvestorsObserver. SIOX received an overall rating of 37, which means that it scores higher than 37% of stocks. Additionally, Sio Gene Therapies Inc scored a 29 in the Healthcare sector, ranking it higher than 29% of stocks in that sector.

Overall Score - 37
SIOX has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on SIOX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Sio Gene Therapies Inc Stock Today?

Sio Gene Therapies Inc (SIOX) stock has gained 3.57% while the S&P 500 is down -1.7% as of 1:34 PM on Friday, Dec 16. SIOX is up $0.01 from the previous closing price of $0.41 on volume of 2,657,345 shares. Over the past year the S&P 500 is lower by -17.97% while SIOX is down -68.42%. SIOX lost -$0.68 per share the over the last 12 months. Click Here to get the full Stock Report for Sio Gene Therapies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App